Al's Comment:

 Very impressive long term results. from phase 1 trials.

Disclaimer: Tocagen is a sponsor of the Musella Foundation

---

Posted on: 05/14/2017

Long-Term Follow-Up Data from 126 Patients with Recurrent High Grade Glioma from Three Phase 1 Trials of Toca 511 and Toca FC: Update and Justification for a Phase 2/3 Trial

http://www.abstractsonline.com/pp8/#!/4399/presentation/1546

 

---

Click HERE to return to brain tumor news headlines.